Cite
APA Citation
Gruber, M., Ferrone, L., Puhr, M., Santer, F. R., Furlan, T., Eder, I. E., Sampson, N., Schäfer, G., Handle, F., & Culig, Z. (2020). p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer. Endocrine-related cancer, 27(3), 187–198. http://access.bl.uk/ark:/81055/vdc_100119759334.0x00003f